INNOVATE Corp.

INNOVATE Corp.

NNYSE:VATE
4.39
USD
-0.18
(-3.94%)
1.18EPS
8.66P/E
102.97MMarket Cap
Mar 10Next Earn
INNOVATE Corp.
NYSE:VATE
(New York Stock Exchange)

Recent

price

4.39

P/E

ratio

8.66

div

yld

4.25%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
287.59
314.3
216.93
162.8
275.07
419.55
414.53
378.48
442.33
238.31
141.5
155.2
209.75
182.09
103.5
94.27
124.26
Revenue per Share
-19.46
-29.55
19.97
78.76
-8.26
-14.92
-28.04
-11.51
34.82
-6.97
-18.87
-29.58
-5.23
-4.81
-3.35
-4.84
0.86
Basic EPS, GAAP
10.26
8.7
-5.86
-23.21
-0.04
-18.43
13.33
-5.86
67.51
19.03
4.6
0.37
-3.87
1.04
-0.93
9.12
7.53
Free Cash Flow per Basic Share
- -
- -
39.66
85.41
0.82
2.13
1.12
0.83
0.45
- -
- -
0.37
0.67
0.28
0.11
0.17
0.19
Dividend per Share
80.29
67.64
48.74
37.91
16.38
11.65
3.5
10.5
14.97
73.05
71.09
-13.15
-15.29
-20.74
-13.6
-17.58
-16.47
Book Value per Share
-133.59
-82.11
-39.32
35.56
-9.31
-13.84
-29.17
-45.31
-71.32
3.98
34.46
-55.98
-55.26
-59.08
-36.16
-38.98
-16.53
Tangible Book Value per Share
1
1
1
1
2
3
4
4
4
5
5
8
8
8
11
13
13
Basic Weighted Avg Shares
282
412
303
231
547
1,121
1,558
1,634
1,977
1,077
717
1,205
1,637
1,423
1,107
1,246
1,665
Sales/Revenue/Turnover
-2.15
-6.4
-10.26
-15.76
-2.53
0.06
-0.1
-0.07
-2.77
6.99
-3.95
-0.88
0.82
1.86
3.61
2.3
5.31
Operating Margin (%)
68
65
43
24
11
32
29
37
39
8
27
38
42
36
33
30
25
Depreciation Expense
-19
-39
28
112
-14
-36
-94
-47
162
-31
-92
-227
-36
-35
-35
-61
13
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
1.32
- -
- -
- -
- -
- -
- -
- -
51.81
Effective Tax Rate (%)
-6.77
-9.4
9.2
48.38
-2.63
-3.17
-6.07
-2.87
8.2
-2.92
-12.83
-18.88
-2.19
-2.47
-3.13
-4.86
0.78
Profit Margin (%)
1
-8
9
43
118
1,953
1,969
2,010
4,896
5,584
294
3
121
105
-92
-582
-576
Working Capital
243
246
127
- -
336
370
428
593
710
660
160
615
738
728
544
123
- -
LT Debt
83
102
69
54
108
121
70
190
202
455
606
-7
-47
-153
-160
-225
-206
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
-6.27
- -
- -
- -
- -
- -
- -
- -
9.7
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
25.03
- -
- -
- -
- -
- -
- -
- -
14.09
Return on Capital (%)
-21.72
-44.74
34.37
181.6
-35.07
-98.7
-375.31
-161.48
271.55
-15.47
-21.51
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
625
564
575
LT Borrowings
69
62
- -
LT Finance Leases
72
56
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
14
14
Market Capitalization
77
255
103

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
407
480
582
Cash, Cash Equivalents & STI
135
88
5
Accounts Receivable, Net
3
1
- -
Inventories
15
15
1
Total Current Liabilities
1,020
1,083
1,158
Payables & Accruals
204
181
32
ST Debt
625
564
575
Deferred Revenue
157
183
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
104.57%
150.33%
40.55%
Free Cash Flow
-468.43%
-579.03%
-1,317.17%
Net Income, GAAP
-12.29%
26.91%
75.14%
Sales/Revenue/Turnover
6.71%
16.24%
12.55%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
315
313
242
237
1,107
2025
274
242
347
383
1,246
2026
365
422
496
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-2.25
1.58
-1.18
-1.29
-3.35
2025
-1.89
-1.67
-0.71
-0.58
-4.84
2026
-1.29
0.78
1.93
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
0.03
0.02
0.02
0.11
2025
0.02
0.06
0.03
0.05
0.17
2026
0.03
0.02
0.08
- -
- -
Business
INNOVATE Corp. (NYSE: VATE) operates as a diversified holding company with subsidiaries focused on infrastructure, life sciences, and spectrum segments primarily in the United States; its infrastructure unit through DBM Global Inc. provides fully integrated construction and professional services including design-assist, modularization, fabrication and erection of structural steel, heavy steel plate, trusses and girders, heavy equipment installation, as well as facility maintenance and shutdown services for critical sectors such as infrastructure and energy; the life sciences segment encompasses Pansend Life Sciences developing innovative healthcare technologies to address unmet needs, R2 Technologies offering an FDA-cleared device to soothe, brighten skin and treat visible signs of aging caused by inflammation in the global aesthetic dermatology market, and MediBeacon providing the FDA-approved Transdermal GFR System (TGFR), a point-of-care product for assessing kidney function in patients with normal or impaired renal function targeting a $7 billion market; the spectrum segment operates through HC2 Broadcasting Holdings Inc. and subsidiaries, owning and managing one of the largest broadcast station groups in the U.S. with 256 stations in 106 markets and 2.3 billion MHz POPs of spectrum for over-the-air broadcasting. Founded in 1994 and headquartered at 295 Madison Avenue, 12th Floor, New York, New York, the company, formerly known as HC2 Holdings, Inc. and tracing roots to Primus Telecommunications Group, rebranded to INNOVATE Corp. in September 2021 to emphasize innovative growth businesses across its portfolio serving industrial, healthcare, biotechnology, and media markets. In a significant recent development, INNOVATE Corp. completed a comprehensive debt refinancing in August 2025, restructuring 81.7% of its total outstanding principal debt as of June 30, 2025, by exchanging $328.1 million of existing senior secured notes for new 10.500% Senior Secured Notes due 2027, $48.7 million convertible senior notes for new 9.5% Convertible Senior Secured Notes, amending various credit facilities, and exchanging preferred stock for additional note principal resulting in a $43.0 million CGIC note, while extending maturities on its revolving credit agreement to September 2026, CGIC note to April 2027, Spectrum Notes to September 2026, and R2 Technologies note to August 2026 to enhance financial flexibility.

Company News

  • INNOVATE Q3 Earnings Call Highlights

  • INNOVATE Corp. (VATE) Q3 2026 Earnings Call Prepared Remarks Transcript

  • INNOVATE Corp. Announces Third Quarter 2026 Results

  • INNOVATE Corp. to Report Third Quarter 2026 Results on November 12th

  • INNOVATE (NYSE:VATE) and MYR Group (NASDAQ:MYRG) Critical Contrast

  • INNOVATE Completes DBM Global Sale, Targets Debt Reduction

  • INNOVATE Completes Sale of DBM Global to IES Holdings

  • Analyzing INNOVATE (NYSE:VATE) & Concrete Pumping (NASDAQ:BBCP)

  • INNOVATE Announces Closing of the Sale of a Controlling Interest in its Broadcasting Segment to CONX

  • VATE Q2 Earnings Improve Y/Y as Infrastructure Revenues Surge

  • MediBeacon® Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology

  • INNOVATE Agrees to $650 Million Sale of DBM Global to IES Holdings

  • IES Holdings to Acquire DBM Global

  • INNOVATE Q2 Earnings Call Highlights

  • INNOVATE Corp. (VATE) Q2 2026 Earnings Call Prepared Remarks Transcript

  • INNOVATE Corp. to Report Second Quarter 2026 Results on August 6th

  • INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend

  • INNOVATE Announces Successful Closing of Broadcasting Refinancing and Agrees to Partial Sale of Broadcasting

  • INNOVATE Q1 Loss Narrows Y/Y on Infrastructure, AI Project Demand

  • INNOVATE Q1 Earnings Call Highlights